UK markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
13.98+0.09 (+0.65%)
At close: 4:00PM EDT
14.00 +0.02 (0.14%)
After hours: 05:21PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close13.89
Open14.01
Bid14.00 x 1200
Ask14.38 x 900
Day's range13.86 - 14.19
52-week range11.80 - 29.65
Volume696,431
Avg. volume1,287,231
Market cap699.727M
Beta (5Y monthly)1.13
PE ratio (TTM)48.21
EPS (TTM)0.29
Earnings date09 Aug 2021 - 13 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est27.63
  • Could The Cara Therapeutics, Inc. (NASDAQ:CARA) Ownership Structure Tell Us Something Useful?
    Simply Wall St.

    Could The Cara Therapeutics, Inc. (NASDAQ:CARA) Ownership Structure Tell Us Something Useful?

    A look at the shareholders of Cara Therapeutics, Inc. ( NASDAQ:CARA ) can tell us which group is most powerful...

  • Is Cara Therapeutics a Buy for Summer 2021?
    Motley Fool

    Is Cara Therapeutics a Buy for Summer 2021?

    The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.

  • Is Cara Therapeutics a Buy?
    Motley Fool

    Is Cara Therapeutics a Buy?

    With the clinical trial process in the rearview mirror, a lot of the risks associated with development are in the past, leaving "only" the risks of competing profitably. Such is the situation of Cara Therapeutics (NASDAQ: CARA), which is developing a drug called Korsuva to treat pruritus. You've probably experienced pruritus (at least to a small degree) before, because it's the sensation of itchiness.